The news of Diane Ladd’s death at 89 has brought attention to a rare but serious lung condition. The legendary actress, known ...

The study authors encourage further research on this topic. Researchers issue warning after discovering overlooked hazard ...

Treatment with Endeavor Biomedicines’ experimental oral therapy ENV-101 (taladegib) improved lung function in people with IPF ...

A biomarker panel for IPF may identify RA patients at higher risk for ILD, supporting biological overlap between IPF and RA-ILD. The study involved over 2500 US veterans and showed strong associations ...

In idiopathic pulmonary fibrosis, the lung tissue thickens and stiffens through proliferation of fibroblasts and invasion by inflammatory cells. One of the drivers of these processes is the enzyme ...

Bristol-Myers Squibb Company remains a solid, cash-generative blue-chip stock, with expected slow growth & patience. Learn more about BMY stock here.

A Phase 2 trial testing experimental therapy CAL101 in people with IPF is recruiting participants. CAL101 has been granted ...

Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.

For U.S. patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slows the decline in forced vital capacity (FVC), according to a study presented at CHEST 2025, the annual meeting of the ...

BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary ...

Results from a US multicenter study presented at CHEST show e-Lung could have sped up Progressive Pulmonary Fibrosis (PPF) diagnosis by up to 21 months CHICAGO, USA and OXFORD, UK October 20 th 2025 – ...